Clostridium difficile toxin A/B gene(C.diff)

ʻO ka wehewehe pōkole:

Hoʻolālā ʻia kēia pahu no ka ʻike in vitro qualitative o clostridium difficile toxin A gene a me toxin B gene i loko o nā laʻana stool mai nā mea maʻi i manaʻo ʻia i ka maʻi clostridium difficile.


Huahana Huahana

Huahana Huahana

inoa huahana

HWTS-OT031A Nucleic Acid Detection Kit no Clostridium difficile toxin A/B gene (C.diff) (Fluorescence PCR)

Palapala

CE

Epidemiology

ʻO Clostridium difficile (CD), kahi gram-positive anaerobic sporogenic Clostridium difficile, ʻo ia kekahi o nā pathogens nui e hoʻoulu ai i nā maʻi ʻōpū nosocomial. ʻO ka maʻi maʻi, ma kahi o 15% ~ 25% o ka maʻi maʻi e pili ana i ka antimicrobial, 50% ~ 75% o ka colitis pili antimicrobial a me 95% ~ 100% o ka pseudomembranous enteritis ke kumu o Clostridium difficile infection (CDI). ʻO Clostridium difficile kahi pathogen conditional, e komo pū me nā ʻano toxigenic a me nā ʻano mea ʻole-toxigenic.

Kanal

FAM tcdAgene
ROX tcdBgene
VIC/HEX Hoomalu Kuloko

Nā ʻāpana ʻenehana

Waihona

≤-18 ℃

Kau-ola 12 mahina
ʻAno Hoʻohālike stool
Tt ≤38
CV ≤5.0%
LoD 200CFU/mL
kikoo E hoʻohana i kēia kit e ʻike ai i nā pathogens ʻē aʻe e like me Escherichia coli, Staphylococcus aureus, Shigella, Salmonella, Vibrio parahaemolyticus, Group B Streptococcus, Clostridium difficile non-pathogenic strains, Adenovirus, rotavirus, norovirus, influenza A virus, influenza B virus a me nā hopena genomic DNA kino a pau.
Nā mea hana pili Hoʻohana ʻia Biosystems 7500 Pūnaehana PCR manawa maoli

Hoʻohana ʻia ʻo Biosystems 7500 Fast Real-Time PCR Systems

QuantStudio®5 Pūnaehana PCR manawa maoli

SLAN-96P Pūnaehana PCR manawa maoli (Hongshi Medical Technology Co., Ltd.)

LightCycler®480 Pūnaehana PCR manawa maoli

LineGene 9600 Plus Pūnaehana ʻike PCR manawa maoli(FQD-96AHangzhouʻenehana bioer)

MA-6000 Mea Hoʻokele Thermal Cycler Manawa maoli (Suzhou Molarray Co., Ltd.)

BioRad CFX96 Pūnaehana PCR Manawa maoli

BioRad CFX Opus 96 Pūnaehana PCR Manawa maoli

Holo Hana

Koho 1.

E hoʻohui i ka 180μL o ka lysozyme buffer i ka precipitate (dilute i ka lysozyme i 20mg / mL me ka lysozyme diluent), pipette e hui maikaʻi, a hana ma 37 ° C no nā minuke 30. E lawe i 1.5mL o RNase / DNase-free centrifuge tube, a hoʻohui.180μL o ka mana maikaʻi a me ka mana maikaʻi ʻole i ke kaʻina. Hoʻohui10μL o ka mana o loko i ka hāpana e ho'āʻoʻia, ka mana maikaʻi, a me ka mana maikaʻiʻole i ke kaʻina, a hoʻohana i ka Nucleic Acid Extraction or Purification Reagent (YDP302) e Tiangen Biotech (Beijing) Co., Ltd. E hoʻohana iā DNase/RNase manuahi H2ʻO no ka elution, a ʻo ka nui o ka elution i ʻōlelo ʻia he 100μL.

Koho 2.

E lawe i 1.5mL o RNase/DNase-free centrifuge tube, a hoʻohui i 200μL o ka mana maikaʻi a me ka mana maikaʻi ʻole i ke kaʻina. Hoʻohui10μL o ka mana o loko i ka hāpana e ho'āʻoʻia, ka mana maikaʻi, a me ka mana maikaʻiʻole i ke kaʻina, a hoʻohana i ka Macro & Micro-Test Viral DNA / RNA Kit (HWTS-3004-32, HWTS-3004-48, HWTS-3004-96) a me ka Macro & Micro-Test Automatic Nucleic Acid Extractor (H6TS-3). Pono e hoʻokō ʻia ka unuhi e like me ke aʻo ʻana no ka hoʻohana ʻana, a ʻo ka nui o ka elution i ʻōlelo ʻia he 80μL.

 


  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou